Petco Love Lost is a free platform that uses AI-powered photo matching to reunite lost pets with their families. When Michael Bown left New York City for a family reunion at the Jersey Shore, he never imagined he'd return to a nightmare. His beloved adopted dog, Millie, just a year old, slipped out of her collar during a walk in the East Village and vanished into the night. What followed was a frantic, emotional and ultimately heartwarming journey, one that highlights the power of community, technology and a little bit of luck. Join The FREE CyberGuy Report: Get my expert tech tips, critical security alerts and exclusive deals -- plus instant access to my free Ultimate Scam Survival Guide when you sign up! Michael's story began with a simple act of trust, leaving Millie in the care of a close friend.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. COVID: Artificial intelligence-generated COVID drug enters clinical trials. WORK TOGETHER: Embracing AI means we must mitigate risk to firms, industries, consumers and society. TERRIFYING TECH: Criminal enterprise flaunts AI in creepy commercial meant for dark web.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. Artificial intelligence is increasingly moving into the health care arena and helping to streamline medical processes -- including the creation of new drugs. Insilico Medicine, an AI-driven biotech company based in Hong Kong and in New York City, recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials. This oral drug is a treatment, not a vaccine.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. In humanity's quest to live longer, healthier lives, technology -- particularly artificial intelligence -- is playing an ever-bigger role and expanding into more areas of health care. A California-based medical technology company named Prenuvo, for instance, offers full-body MRI scans that leverage AI to screen patients for over 500 conditions -- including tumors, aneurysms and cysts -- in less than an hour. Now, Prenuvo is announcing a partnership with Cenegenics, a Las Vegas-based company that offers "personalized performance health age management" for its patients.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. AI experts and tech-inclined political scientists are sounding the alarm on the unregulated use of AI tools going into an election season. Generative AI can not only rapidly produce targeted campaign emails, texts or videos, it also could be used to mislead voters, impersonate candidates and undermine elections on a scale and at a speed not yet seen. A booth is ready for a voter, Feb. 24, 2020, at City Hall in Cambridge, Mass., on the first morning of early voting in the state.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. Imagine a world where "interspecies communication" isn't the stuff of sci-fi fantasies - instead, a reality where humans can chit-chat with their furry, feathery, and scaly friends. This is where AI swoops in like a superhero, with researchers using algorithms to decipher animal vocalizations, movements, and even facial expressions. The Earth Species Project, a non-profit organization dedicated to decoding animal communication, is at the forefront of this groundbreaking research.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. The accessibility of artificial intelligence (AI) will change the international landscape to empower "bad actor" strongman regimes and lead to unprecedented social disruptions, a risk analysis expert told Fox News Digital. "We know that when you have a bad actor, and all they have is a single-shot rifle as opposed to an AR-15, they can't kill as many people, and the AR-15 is nothing compared to what we are going to see from artificial intelligence, from the disruptive uses of these tools," said Ian Bremmer, founder and president of political risk research firm Eurasia Group. In referencing improved capabilities for autonomous drones and the ability to develop new viruses, among others, Bremmer said that "we've never seen this level of malevolent power that will be in the hands of bad actors."

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. Artificial intelligence already has a lengthy track record in the field of weather prediction, where it has helped prognosticators make faster, more accurate forecasts for nearly three decades. But now, AI has the potential to take the next step when it comes to predicting sun, rain, wind and snow by doing the work on its own, without using various models that human forecasters have relied on for generations. Hendrik Tolman, senior adviser for advanced modeling systems at the National Weather Service, told Fox News Digital this possibility is now on the horizon and is actively being explored.

PsychoGenics CEO Emer Leahy of Paramus, New Jersey, explains how the first potential AI-discovered treatment for schizophrenia was developed through machine learning. Fox News Digital spoke with her. As the world of artificial intelligence continues to evolve, a New Jersey biotech company is taking AI capabilities to the next level. After decades of working with AI-driven phenotypic platforms in an attempt to develop drugs for mental illness, PsychoGenics has had a breakthrough with one compound that aims to treat schizophrenia. PsychoGenics president and CEO Emer Leahy spoke to Fox News Digital in a recent on-camera interview, explaining that she and her team are closer than ever to developing what she said is the first-ever AI-discovered drug.

When we compare the influences of two causes on an outcome, if the conclusion from every group is against that from the conflation, we think there is Simpson's Paradox. The Existing Causal Inference Theory (ECIT) can make the overall conclusion consistent with the grouping conclusion by removing the confounder's influence to eliminate the paradox. The ECIT uses relative risk difference Pd = max(0, (R - 1)/R) (R denotes the risk ratio) as the probability of causation. In contrast, Philosopher Fitelson uses confirmation measure D (posterior probability minus prior probability) to measure the strength of causation. Fitelson concludes that from the perspective of Bayesian confirmation, we should directly accept the overall conclusion without considering the paradox. The author proposed a Bayesian confirmation measure b* similar to Pd before. To overcome the contradiction between the ECIT and Bayesian confirmation, the author uses the semantic information method with the minimum cross-entropy criterion to deduce causal confirmation measure Cc = (R -1)/max(R, 1). Cc is like Pd but has normalizing property (between -1 and 1) and cause symmetry. It especially fits cases where a cause restrains an outcome, such as the COVID-19 vaccine controlling the infection. Some examples (about kidney stone treatments and COVID-19) reveal that Pd and Cc are more reasonable than D; Cc is more useful than Pd.